Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Saturday, December 31, 2022.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2022 (2022-12-31): -1263.55%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-465.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-139.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-126.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Eloxx Pharmaceuticals, Inc.
Market Cap
$51.99M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-465.02%
3Y Avg
-139.08%
5Y Avg
-126.63%
Market Cap
$51.88M
Return on Invested Capital (ROIC)
-40.53%
TTM Avg
-31.24%
3Y Avg
-37.98%
5Y Avg
-33.19%
Market Cap
$52.60M
Return on Invested Capital (ROIC)
-17.88%
TTM Avg
-7.19%
3Y Avg
2.05%
5Y Avg
4.26%
Market Cap
$51.23M
Return on Invested Capital (ROIC)
-157.40%
TTM Avg
-135.65%
3Y Avg
-123.35%
5Y Avg
-111.97%
Market Cap
$51.19M
Return on Invested Capital (ROIC)
-60.40%
TTM Avg
-39.64%
3Y Avg
-170.44%
5Y Avg
-270.57%
Market Cap
$52.83M
Return on Invested Capital (ROIC)
-353.68%
TTM Avg
-236.80%
3Y Avg
-128.97%
5Y Avg
-95.70%
Market Cap
$51.12M
Return on Invested Capital (ROIC)
-38.04%
TTM Avg
-22.77%
3Y Avg
-89.18%
5Y Avg
-83.00%
Market Cap
$50.28M
Return on Invested Capital (ROIC)
13.63%
TTM Avg
32.98%
3Y Avg
9.79%
5Y Avg
24.14%
Market Cap
$53.70M
Return on Invested Capital (ROIC)
-31665.34%
TTM Avg
-44.53%
3Y Avg
-44.53%
5Y Avg
-44.53%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $51.99M | N/A | -465.02% | -139.08% | -126.63% |
| ImageneBio Inc (IMA)vs › | $51.88M | -40.53% | -31.24% | -37.98% | -33.19% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -17.88% | -7.19% | 2.05% | 4.26% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -157.40% | -135.65% | -123.35% | -111.97% |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | -60.40% | -39.64% | -170.44% | -270.57% |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | -353.68% | -236.80% | -128.97% | -95.70% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | -38.04% | -22.77% | -89.18% | -83.00% |
| biote Corp. (BTMD)vs › | $50.28M | 13.63% | 32.98% | 9.79% | 24.14% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | -31665.34% | -44.53% | -44.53% | -44.53% |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | -208.76% | -1171.68% | -1173.13% | -939.08% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2022-12-31 | -1263.55% |
| 2022-09-30 | -474.91% |
| 2022-06-30 | -282.82% |
| 2022-03-31 | -182.88% |
| 2021-12-31 | -120.95% |
| 2021-09-30 | -80.58% |
| 2021-06-30 | -64.72% |
| 2021-03-31 | -207.75% |
| 2020-12-31 | -132.20% |
| 2020-09-30 | -123.87% |
| 2020-06-30 | -119.54% |
| 2020-03-31 | -117.25% |
| 2019-12-31 | -97.27% |
| 2019-09-30 | -87.50% |
| 2019-06-30 | -73.16% |
| 2019-03-31 | -102.46% |
| 2018-12-31 | -106.45% |
| 2017-06-30 | -61.60% |
| 2017-03-31 | -45.74% |
| 2016-12-31 | -53.76% |
| 2016-09-30 | -50.77% |
| 2016-06-30 | -41.93% |
